Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis

Korean Journal of Laboratory Medicine

Volumn 28, Issue 3, 2008, Pages 201-206

  Chae, Hyojin ^a   Lee, Je Hoon ^a   Lim, Jihyang ^a   Kim, Myungshin ^a   Kim, Yonggoo ^a   Han, Kyungja ^a   Kang, Chang Suk ^a   Shim, Sang In ^a   Kim, Jin Il ^a   Park, Soo Heon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Atrophic gastritis; Gastric cancer; Pepsinogen; Pepsinogen I II ratio

Indexed keywords

PEPSINOGEN; PEPSINOGEN II;

ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; ATROPHIC GASTRITIS; BLOOD; EVALUATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; PHOTOMETRY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PEPSINOGEN A; PEPSINOGEN C; REAGENT KITS, DIAGNOSTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 60749102230     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.3.201     Document Type: Article

References (16)

1. Shin HR, Jung KW, Won YJ, Park JG. 2002 annual report of Korea central cancer resistry: based on registered data from 139 hospitals. Cancer Res Treat 2004;36:103-14.
2. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7. (Pubitemid 16179958)
3. Di Gregorio C, Morandi P, Fante R, De Gaetani C. Gastric dysplasia. A follow-up study. Am J Gastroenterol 1993;88:1714-9. (Pubitemid 23298120)
4. Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971; 61:185-8.
5. Samloff IM and Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973;65:36-42.
6. Korstanje A, den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002;236(S): S22-6.
7. Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, et al. Serum pepsinogen and gastric cancer screening. Intern Med 2007; 46:261-6. (Pubitemid 46488392)
8. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002;28:505-15. (Pubitemid 35174968)
9. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut 2002;50:13-8. (Pubitemid 34028296)
10. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, et al. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Caner Res 1995;86:64-71.
11. Miki K and Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007;8:8-14. (Pubitemid 46189204)
12. Paik CN, Chung IS, Nam KW, Kwon JH, Chang JH, Suh JP, et al. Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and negative subjects. Korean J Gastroenterol 2007;50:84-91.
13. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F; Eurohepygast Study Group. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239-47. (Pubitemid 36606340)
14. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata G, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41. (Pubitemid 17065789)
15. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino AM. Accuracy of screening for gastric cancer. J Gastroenterol 1995;30: 452-60.
16. Aoki K, Misumi J, Kimura T, Zhao W, Xie T. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study. J Epidemiol 1997;7:143-51. (Pubitemid 127824096)